Survival Low in Some After Recurrence of Cutaneous Squamous-Cell Carcinoma Survival Low in Some After Recurrence of Cutaneous Squamous-Cell Carcinoma
Patients with cutaneous squamous-cell cancer of the head and neck who have disease recurrence after definitive treatment with surgery and postoperative radiotherapy have poor survival, according to a retrospective study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 14, 2019 Category: Radiology Tags: Hematology-Oncology News Source Type: news

New Tool Predicts Post-Surgery Problems in Head and Neck Cancer New Tool Predicts Post-Surgery Problems in Head and Neck Cancer
A new preoperative risk index can help predict short-term adverse events (AEs) following surgery for head and neck cancer, according to Canadian researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 1, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Wallet Pains for Head and Neck Cancer Patients (CME/CE)
(MedPage Today) -- HNC patients demographically distinct and " uniquely disadvantaged " (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 28, 2019 Category: Surgery Source Type: news

Mental Health Disorders Up After Head & amp; Neck Cancer Diagnosis
THURSDAY, Feb. 28, 2019 -- In patients with head and neck cancer (HNC), the prevalence of mental health disorders (MHDs) is significantly higher after cancer diagnosis, according to a study published online Feb. 28 in JAMA Otolaryngology-Head&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2019 Category: Pharmaceuticals Source Type: news

How common are mental health disorders after diagnosis of head and neck cancer?
(JAMA Network) Treatment for head and neck cancer (HNC) might cure the disease but it also can result in adverse effects such as disfigurement and speech difficulties, which can affect quality of life for patients. Using information from a large insurance claims database, this study examined how common mental health disorders were in patients with HNC and how they were associated with diagnosis and treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 28, 2019 Category: Cancer & Oncology Source Type: news

Comparing financial burdens of head and neck cancer with other cancers
(JAMA Network) Head and neck cancer is expensive to treat and the disease can create long-term health needs. Using national survey data over nearly two decades, this study assessed the financial burdens of head and neck cancers compared with other cancers among nearly 17,000 patients with cancer, of whom 489 reported head and neck cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2019 Category: Cancer & Oncology Source Type: news

$1.4 million VA grant will help researcher study radiation resistance in head and neck cancer
(University of Cincinnati Academic Health Center) A University of Cincinnati cancer researcher received a $1.4 million federal grant to study radiation resistance in head and neck cancer and ways to target molecular pathways in patients to make this form of treatment more effective. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 18, 2019 Category: Cancer & Oncology Source Type: news

Infographic: HPV head and neck cancers
Learn more about head and neck cancers. Other health tip infographics: mayohealthhighlights.startribune.com? (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 13, 2019 Category: Databases & Libraries Source Type: news

Factors associated with suicidal ideation risk in head and neck cancer: a longitudinal study - Chang DC, Chen AW, Lo YS, Chuang YC, Chen MK.
OBJECTIVES/HYPOTHESIS: The risk factors associated with suicidal ideation among patients with head and neck cancer (HNC) have rarely been investigated. Thus, this study proposed an effective screening model to facilitate the identification of patients with... (Source: SafetyLit)
Source: SafetyLit - February 2, 2019 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Head, Neck Cancers Up Among 9-11 Responders: Study
FRIDAY, Feb. 1, 2019 -- Head and neck cancers among a group of first responders to the 9/11 World Trade Center terrorist attacks are significantly higher than expected, a new study says. Rutgers University researchers found that diagnoses of these... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 1, 2019 Category: General Medicine Source Type: news

NSAIDs Tied to Improved Survival in Head and Neck Cancer Subset NSAIDs Tied to Improved Survival in Head and Neck Cancer Subset
Regular use of NSAIDs dramatically improved disease-specific survival in head and neck cancer patients, but only those with PIK3CA mutations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 29, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

9/11 Responders May Have Higher Head, Neck Cancer Risk
TUESDAY, Jan. 29, 2019 -- There may be a significant, emerging risk for human papillomavirus (HPV)-related head and neck cancers (HNC) among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news

Aspirin, ibuprofen increase head, neck cancer survival rates
Taking aspirin and ibuprofen regularly significantly improves survival rates for about 33 percent of patients with head and neck cancer, a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 28, 2019 Category: Consumer Health News Source Type: news

NSAIDs May Up Survival in Certain Head and Neck Cancers
(MedPage Today) -- Advantage in PIK3CA-positive patients regardless of HPV status (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 28, 2019 Category: Hematology Source Type: news

Aspirin offers fresh hope to patients with head cancer
COMMON painkillers such as aspirin and ibuprofen could triple a patient's chances of surviving head and neck cancer, a study revealed yesterday. More than a third of people with head and neck cancer have a gene mutation that means they could benefit from regularly taking non-steroidal anti-inflammatory drugs . (Source: Daily Express - Health)
Source: Daily Express - Health - January 26, 2019 Category: Consumer Health News Source Type: news

Medical News Today: How aspirin may benefit some people with head and neck cancer
Regular use of aspirin or other NSAIDs increased survival in people with head and neck squamous cell carcinoma and alteration in the PIK3CA gene. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 25, 2019 Category: Consumer Health News Tags: Head and Neck Cancer Source Type: news

Daily aspirin could boost survival rates from head and neck cancer by up to 78%
Researchers at the University of California San Francisco looked at five-year survival rates for people diagnosed with the disease. They found a third or more patients benefited from the pill. (Source: the Mail online | Health)
Source: the Mail online | Health - January 25, 2019 Category: Consumer Health News Source Type: news

Study suggests aspirin may help some patients survive head and neck cancer
Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease, according to a study led by Professor Jennifer Grandis at the University of California, San Francisco. The study, published today in the Journal of Experimental Medicine, indicates that NSAIDs are effective in patients with mutations in a gene called PIK3CA, and the researchers suggest this is because NSAIDs lower the levels of an inflammatory molecule called prostaglandin E2. (Source: World Pharma News)
Source: World Pharma News - January 25, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Common pain reliever can improve survival in head and neck cancer
(University of California - San Francisco) Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 25, 2019 Category: Cancer & Oncology Source Type: news

Study suggests aspirin may help some patients survive head and neck cancer
(Rockefeller University Press) Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease, according to a study led by Professor Jennifer Grandis at the University of California, San Francisco. The study, which will be published Jan. 25 in the Journal of Experimental Medicine, indicates that NSAIDs are effective in patients with mutations in a gene called PIK3CA, likely by lowering the levels of an inflammatory molecule called prostaglandin E2. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 25, 2019 Category: Cancer & Oncology Source Type: news

World Trade Center responders at increased risk for head and neck cancers
(Rutgers University) A Rutgers study has found a significant increase in head and neck cancers among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC), pointing to newly emerging risks that require ongoing monitoring and treatment of those who were exposed during the initial response. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Advanced squamous cell carcinoma of the head and neck: Pembrolizumab prolongs survival
(Institute for Quality and Efficiency in Health Care) quamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable. The goal is then to prolong the remaining lifetime while maintaining the best possible quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

Persistent Opioid Use High in Head, Neck Cancer Patients
FRIDAY, Jan. 11, 2019 -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery. Jessica... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2019 Category: Pharmaceuticals Source Type: news

Novel biomarker appears predictive of outcome in patients with HPV-related head and neck cancers
(University of Texas M. D. Anderson Cancer Center) Rather than classifying based solely on HPV status, MD Anderson researchers have discovered a new biomarker for head and neck cancers that may enable clinicians to better predict patient outcomes and lower treatment intensity to reduce side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2019 Category: Cancer & Oncology Source Type: news

MD Anderson Cancer Center and Nanobiotix announce a large-scale, comprehensive clinical collaboration on NBTXR3
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 7, 2019 Category: Cancer & Oncology Source Type: news

New approach may curb treatment-related skin fibrosis in cancer patients
(University Health Network) A clinical-scientific team specializing in head-and-neck cancer has identified a way to manipulate metabolism to potentially curb skin fibrosis -- a common side effect of radiotherapy affecting quality of life of cancer survivors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 7, 2019 Category: Cancer & Oncology Source Type: news

U.S. Quality of Care for Head and Neck Cancers Varies Widely U.S. Quality of Care for Head and Neck Cancers Varies Widely
The quality of care received by patients with head and neck cancers in the U.S. varies widely and is unaffected by the size of the hospital or the volume of patients treated in a year, a study shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Opioid use and misuse following treatment for head and neck cancer
(University of Colorado Anschutz Medical Campus) Six months after treatment ended, 7 percent of patients remained on opioid pain medications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 26, 2018 Category: Cancer & Oncology Source Type: news

U.S. quality of care for head and neck cancers varies widely
(Reuters Health) - The quality of care received by patients with head and neck cancers in the U.S. varies widely and is unaffected by the size of the hospital or the volume of patients treated in a year, a study shows. (Source: Reuters: Health)
Source: Reuters: Health - December 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Health Tip: Avoid Hoarseness
-- Hoarseness tends to happen when there is a problem with the vocal cords, the American Academy of Otolaryngology Head and Neck Surgery says. Common reasons for hoarseness include laryngitis, non-cancerous vocal cord lesions, pre-cancerous or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 21, 2018 Category: General Medicine Source Type: news

Immunotherapeutic Approaches to the Management of Head and Neck Cancer
Experts discuss the PD-1 checkpoint inhibitors nivolumab and pembrolizumab in the management of head and neck cancer, and how to choose between them. (Source: CancerNetwork)
Source: CancerNetwork - December 17, 2018 Category: Cancer & Oncology Authors: Xinyu Nan, MD, Kathryn A. Gold, MD, Ezra Cohen, MD Source Type: news

Ask Well: Do Cruciferous Vegetables Really Fight Cancer?
You cannot go wrong incorporating a lot of cruciferous vegetables, which include broccoli and brussels sprouts as well as dark leafy greens like kale and arugula, in your diet. (Source: NYT Health)
Source: NYT Health - December 7, 2018 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Vegetables Head and Neck Cancer Colon and Colorectal Cancer Lung Cancer Breast Cancer Diet and Nutrition Vitamins Dietary Supplements and Herbal Remedies Throat Prostate Gland Source Type: news

AstraZeneca's Imfinzi fails to meet main goals in head and neck cancer study
AstraZeneca Plc's immunotherapy Imfinzi did not meet the main goals of a late-stage study testing the drug as a treatment for advanced head and neck cancer, the London-listed drugmaker said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - December 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Do Oral Side Effects Affect Fentanyl Delivery in Head & amp; Neck Cancer Patients?
Erin McMenamin, CRNP, of Penn Medicine, discusses how oral side effects affect head and neck cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - December 4, 2018 Category: Cancer & Oncology Authors: Lori Smith, BSN, MSN, CRNP Source Type: news

Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer
(University of California - San Diego) A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 30, 2018 Category: International Medicine & Public Health Source Type: news

Immunotherapy keeps some advanced head and neck cancer patients alive for over three years
(Institute of Cancer Research) A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.Overall, the drug pembrolizumab had significant benefits for patients, with 37 per cent of patients who received it surviving for a year or more, compared with only 26.5 per cent of those on standard care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 30, 2018 Category: Cancer & Oncology Source Type: news

One in Five Readmitted After Head, Neck Cancer Reconstruction
TUESDAY, Nov. 27, 2018 -- Nearly one in five patients undergoing head and neck cancer surgery reconstruction is readmitted within 30 days of surgery, according to a study published online Nov. 8 in JAMA Facial Plastic Surgery. Alexander N. Goel,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2018 Category: Pharmaceuticals Source Type: news

CT lung screening can catch recurring head, neck cancer
CT lung screening may have added value in cancer detection beyond the chest,...Read more on AuntMinnie.comRelated Reading: PET/CT remains best option for head, neck cancer PET/CT after therapy avoids surgery for head, neck cancer Lung plus head/neck cancer screening delivers high yields PET/CT details hint at survival of head and neck cancer patients IMRT confers survival benefit for head and neck cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2018 Category: Radiology Source Type: news

Timely care key to improving survival rates and racial disparities
(Medical University of South Carolina) Postoperative radiotherapy is needed within six weeks of surgery in patients with head and neck cancer, but delays are common. Researchers at MUSC and Hollings Cancer Center report that 56 percent of African American patients experienced a delay in care while only 43 percent of white patients did. Small changes to the way that cancer care is delivered can decrease these delays, but more research is needed to pinpoint the exact causes behind it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

Public awareness of mouth cancer symptoms low, despite sharp rise in cases
Disease accounts for more than 8000 diagnoses and nearly 3000 deaths every year Related items fromOnMedica JCVI recommends universal HPV vaccination One or two doses of HPV jab may be enough Scotland launches its ‘Detect Cancer Early’ campaign Ditch habit for longer survival after head and neck cancer, smokers urged Obesity as cause of cancer set to overtake smoking (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 5, 2018 Category: UK Health Source Type: news

Head and Neck Cancer Survivors Have Increased Suicide Risk
Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 2, 2018 Category: Psychiatry Tags: Oncology, ENT, Psychiatry, Journal, Source Type: news

Head and Neck Cancer Survivors Have Increased Suicide Risk
FRIDAY, Nov. 2, 2018 -- Head and neck cancer (HNC) survivors have an increased risk for suicide compared with other cancer survivors, according to a study published online Oct. 18 in Cancer. Nosayaba Osazuwa-Peters, Ph.D., M.P.H., from the St. Louis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2018 Category: Pharmaceuticals Source Type: news

Head and neck cancer survivors at increased risk of suicide
(Saint Louis University) Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 25, 2018 Category: Cancer & Oncology Source Type: news

Chemo-Free Therapy for Head and Neck Cancer a Step Closer Chemo-Free Therapy for Head and Neck Cancer a Step Closer
Patients with head and neck cancer who express relatively high levels of PD-L1 could eventually be treated with immunotherapy rather than chemotherapy, new trial data suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

HPV blood test shows promise for tracking head and neck cancer after treatment
(UNC Lineberger Comprehensive Cancer Center) Researchers will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology in San Antonio on Tuesday, Oct. 23, from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2018 Category: Cancer & Oncology Source Type: news

Immunotherapy improves survival in metastatic or recurrent head and neck cancer
(European Society for Medical Oncology) Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasised, according to late-breaking results from the KEYNOTE-048 study reported at the ESMO 2018 Congress in Munich. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 22, 2018 Category: International Medicine & Public Health Source Type: news

Immunotherapy effective as first-line treatment for advanced head and neck cancer
(Institute of Cancer Research) Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.Patients lived for longer and had far lower rates of side-effects if they took the immunotherapy drug pembrolizumab than those who received an 'extreme' combination of two chemotherapies and a targeted drug. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 22, 2018 Category: International Medicine & Public Health Source Type: news

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer
(American Society for Radiation Oncology) Combinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial has now determined that cisplatin chemotherapy, combined with radiation therapy, produces the best results and should be considered the standard of care. Findings will be presented in a news briefing Tuesday at 3 p.m. ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

La Jolla Institute receives $ 4.5 million Cancer Moonshot award
(La Jolla Institute for Allergy and Immunology) Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million as part of the National Cancer Institute's Cancer Moonshot initiative. The funding will support research to develop new and improved immunotherapeutic treatment options for patients with head and neck cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 18, 2018 Category: Cancer & Oncology Source Type: news

' Revolutionary' Data to Be Presented at ESMO 2018'Revolutionary' Data to Be Presented at ESMO 2018
Evolutions and even revolutions are expected when the latest data in head and neck cancer, renal cell carcinoma, breast cancer, and ovarian cancer are presented at the leading European cancer meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news